Skip to main content
NCBI home page
PLOS One logoLink to PLOS One
. 2017 Apr 6;12(4):e0175659. doi: 10.1371/journal.pone.0175659

Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo

Anilkumar C Nirvanappa, Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, Hanumappa Ananda, Alexey Yu Sukhorukov, Muthu K Shanmugam, Mahalingam S Sundaram, Siddaiah Chandra Nayaka, Kesturu S Girish, Arunachalam Chinnathambi, M E Zayed, Sulaiman Ali Alharbi, Gautam Sethi, Basappa, Kanchugarakoppal S Rangappa
PMCID: PMC5383341  PMID: 28384360

Fig 2 appears incorrectly in the published article. Please see the correct Fig 2 and its caption here.

Fig 1. HCT116 cells were treated with different doses of API (0.5, 1, 5, and 10 μM) for 48 h, harvested and stained with propidium iodide and subjected to flow cytometry.

Fig 1

Open in a new tab

Histogram obtained indicated the accumulation cells in sub-G1 phase.

Reference

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES